✦ LIBER ✦

Effect of ipriflavone in established osteoporosis, and long-term safety

✍ Scribed by D. Agnusdel

Publisher: Springer-Verlag
Year: 1996
Tongue: English
Weight: 99 KB
Volume: 6
Category: Article
ISSN: 0937-941X
DOI: 10.1007/bf02500771

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy of ipriflavone in established o

Efficacy of ipriflavone in established osteoporosis and long-term safety

✍ D. Agnusdei; L. Bufalino 📂 Article 📅 1997 🏛 Springer 🌐 English ⚖ 533 KB

Mechanism of action, clinical efficacy a

Mechanism of action, clinical efficacy and safety of ipriflavone in osteoporosis

📂 Article 📅 1996 🏛 Springer-Verlag 🌐 English ⚖ 51 KB

DXA assessment of the synergistic effect

DXA assessment of the synergistic effects of long-term ipriflavone treatment and activities of daily living on bone mass in osteoporosis

✍ Sumio Goto; Makoto Kurihara; Masatsune Yamagata; Syuichi Hyakutake; Hideshige Mo 📂 Article 📅 1993 🏛 Springer 🌐 English ⚖ 478 KB

Effects of long-term alendronate treatme

Effects of long-term alendronate treatment on bone histomorphometry in postmenopausal osteoporosis

✍ P J Meunier 📂 Article 📅 1996 🏛 Springer-Verlag 🌐 English ⚖ 172 KB

Long-Term Safety and Effectiveness of th

Long-Term Safety and Effectiveness of the “OptEase” Vena Cava Filter

✍ Sanjeeva P. Kalva; Theodore C. Marentis; Kalpana Yeddula; Bhanusupriya Somarouth 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 172 KB

Long-term safety and efficacy of long-ac

Long-term safety and efficacy of long-acting risperidone in elderly psychotic patients

✍ Werner Kissling; Per Glue; Rossella Medori; Steve Simpson 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 144 KB 👁 1 views

## Abstract This subgroup analysis of the 6‐month, open‐label Switch to Risperidone Microspheres (StoRMi) trial evaluated long‐term safety and efficacy of a direct conversion to risperidone long‐acting injectable (RLAI) in 52 elderly patients (≥65 years) with psychosis stabilized on oral or depot a